Repeat stereotactic body radiation therapy is a safe, effective salvage therapy for patients with recurrent spinal metastases after initial same vertebral-level SBRT local failure. https://t.co/iDLkzFBoXJ @SuchetTaori @SamuelAdida @UPMCPhysicianEd

… and that’s a wrap! Great #AARN2025 @theABTA annual meeting, congrats Will and @ZhaohuiWang5 on putting together an exceptional program! Great to see so many friends and colleagues, looking forward to continued collaborations! #BTSM

Radiosurgery provides local control and pain palliation with minimal rates of toxicity in a challenging patient population with lung cancer spinal metastases. https://t.co/CUdhcKGADm @SamuelAdida @SuchetTaori @pascalzinn @UPMCPhysicianEd @JNeurooncol

Honored to have received the Lunsford and Leksell Radiosurgery Award from the @NSTumorSection and @CNS_Update. Thankful to my @PittCIGNS radiosurgery mentors: Dr. Peter Gerszten, Dr. @hadjiMDPhD, Dr. @pascalzinn, Dr. Roberta Sefcik, Dr. John Flickinger, and Dr. L. Dade Lunsford.

In honor of #NeurosurgeryAwarenessMonth, we're thrilled to highlight how one seed of support can lead to breakthrough innovation in patient care, thanks to the support of @NREFORG Meet Aditya Mittal, a 2022 NREF Medical Student Summer Research Fellowship recipient from the

Stereotactic radiosurgery is safe and effective in managing small to medium sized superior sagittal sinus invading meningiomas, especially when the tumors involve the posterior one-third of the SSS. https://t.co/fAWB9JK0tM @weizhishuo @hadjiMDPhD @Elekta @IntRRF

Upfront stereotactic body radiotherapy alone for spinal metastases provides durable long-term local tumor control and sustained pain relief with minimal toxicity. https://t.co/Iy4qrPuwF7 @SuchetTaori @SamuelAdida @pascalzinn @UPMCPhysicianEd

Peter Gerszten will present a talk on “Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers” on the @SeattleSciFdtn Tumor Talk webinar June 9 at 4p EST. Register to watch via Zoom at https://t.co/tivXVG45ue. @SeattleSciFdtn @JNeurooncol

Spine SRS for Intradural Tumors · 207 tumors · Median dose SRS 14 Gy, fSRS 21/3 · 90% LC 10 yr · MVA: Absence NF1, Single frac SRS(despite larger tumors) pred ↑↑LC https://t.co/HsYEbPT4sH

@jasonpsheehan delivering our annual @NSTumorSection Ronald Bittner lectureship @AANSNeuro. Moving the needle forward on treating meningiomas with SRS.

Stereotactic radiosurgery for spinal and sacral chordomas provides durable local control and symptom relief with acceptable toxicity, both when used alone and as an adjunct to surgery. https://t.co/u8qWh4EQGR @TheJNS @SamuelAdida @SuchetTaori @UPMCPhysicianEd

Stereotactic body radiation therapy offers effective local tumor control and pain palliation with minimal toxicity for gastrointestinal cancer spinal metastases. https://t.co/GoIVfybzZ0 @SamuelAdida @UPMCHillmanCC @SuchetTaori @pascalzinn

Thankful to @theABTA and mentors Dr. Jeremy Rich, Dr. @ShuaiWang_sdu, and all @PittNeurosurg for helping advance science for brain tumors

Circulating biomarkers 🔥 topic! Outstanding work Pitt med students, Neurosurgery residents and research fellows @PittNeurosurg @PittTweet @pittnsgy @UPMCHillmanCC @UPMCnews

#CARTcells for #DIPG #DMG clinical trial (1st arm) results are out today. Full Tweetorial coming, but first want to share the story of a patient whose #DIPG has disappeared for over 3 years. It is a milestone and moment of hope on a journey filled with so much grief. “There’s a

Spine stereotactic body radiation therapy confers low rates of local failure and toxicity for patients with multilevel disease, which was previously considered a relative contraindication. https://t.co/MsftoRgeFn @SamuelAdida @pascalzinn @UPMCPhysicianEd @SuchetTaori

New! Online now: Metabolic regulation of the glioblastoma stem cell epitranscriptome by malate dehydrogenase 2 https://t.co/otkFAGYKMj

Spine radiosurgery is safe, effective in treatment of benign intradural tumors. One of largest single-institution studies to date shows 10-year LC at 90% with marked improvement to pain and neurological deficit. https://t.co/YCemJbynIa @SamuelAdida @UPMCPhysicianEd @SuchetTaori

Congratulations to L. Dade Lunsford on his receipt of the Founder’s Laurel Award at this year's CNS annual meeting in Houston. The award recognizes individuals who have made exceptional contributions to neurosurgery education. @CNS_Update #2024CNS @PittTweet @UPMC @PittCIGNS

Radiosurgery as a primary or adjuvant treatment modality for prostate cancer spinal metastases confers durable local control and moderate pain relief with minimal toxicity. https://t.co/GrAR3hP5I3 @SamuelAdida @SuchetTaori